Kearney, J. A. (2017). Precision Medicine: NMDA Receptor-Targeted Therapy for GRIN2D Encephalopathy. Epilepsy Currents, 17(2), 112. https://doi.org/10.5698/1535-7511.17.2.112
Chicago Style (17th ed.) CitationKearney, Jennifer A. "Precision Medicine: NMDA Receptor-Targeted Therapy for GRIN2D Encephalopathy." Epilepsy Currents 17, no. 2 (2017): 112. https://doi.org/10.5698/1535-7511.17.2.112.
MLA (9th ed.) CitationKearney, Jennifer A. "Precision Medicine: NMDA Receptor-Targeted Therapy for GRIN2D Encephalopathy." Epilepsy Currents, vol. 17, no. 2, 2017, p. 112, https://doi.org/10.5698/1535-7511.17.2.112.
Warning: These citations may not always be 100% accurate.